Canada markets open in 2 hours 11 minutes

WPD Pharmaceuticals Inc. (WBIO.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.29000.0000 (0.00%)
At close: 3:17PM EDT
Currency in CAD

Valuation Measures

Market Cap (intraday) 532.9M
Enterprise Value 330.21M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)13.18
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7-3.52

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-72.64%
S&P500 52-Week Change 345.07%
52 Week High 31.1600
52 Week Low 30.0000
50-Day Moving Average 30.3209
200-Day Moving Average 30.3095

Share Statistics

Avg Vol (3 month) 337.13k
Avg Vol (10 day) 316.74k
Shares Outstanding 5113.44M
Implied Shares Outstanding 6N/A
Float 55.18M
% Held by Insiders 144.98%
% Held by Institutions 10.00%
Shares Short (Mar. 14, 2021) 420.02k
Short Ratio (Mar. 14, 2021) 40.99
Short % of Float (Mar. 14, 2021) 4N/A
Short % of Shares Outstanding (Mar. 14, 2021) 40.02%
Shares Short (prior month Feb. 11, 2021) 4231.54k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-208.3k
EBITDA -8.59M
Net Income Avi to Common (ttm)-16.18M
Diluted EPS (ttm)-0.1430
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.7M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)15.45k
Total Debt/Equity (mrq)0.63
Current Ratio (mrq)1.66
Book Value Per Share (mrq)0.02

Cash Flow Statement

Operating Cash Flow (ttm)-756.63k
Levered Free Cash Flow (ttm)N/A